Submitted by Anonymous (not verified) on 26 May 2025 - 15:39
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised